The first investor chat took place on October 28 this year. NanoGroup S.A. “NanOX System – what is it?”. The event was attended by Przemysław Mazurek (President of the Management Board), Piotr Mierzejewski (Vice President of the Management Board) and Piotr Burliński (Chief Operating Officer).
During the first part of the meeting, the problem and the scale of demand for kidney transplants in the world were presented. The second part was devoted to presenting the methods of solving this problem developed by NanoGroup S.A., which is the entire NanOX system, a solution for extracorporeal storage of organs for transplantation. The last part presented development and commercialization plans.
The full transcript of the investor chat, along with answers to questions, is available on stockwatch.pl: CLICK HERE
NanOx is a breakthrough technology that allows for organ perfusion in extracorporeal conditions at a temperature close to physiological. The system consists of a universal perfusion device NanOX Recovery box, a perfusion set (a disposable set of equipment required for each perfusion), a specialized perfusion fluid based on nanotechnology and an original perfusion procedure. This solution is a response to the global problem of an insufficient number of organs for transplantation – it is estimated that currently about half a million patients are waiting for a kidney transplant.
Source of information: stockwatch.pl